{
    "Trade/Device Name(s)": [
        "iQ\u00ae 200 Urine Analyzer Body Fluids Module"
    ],
    "Submitter Information": "Iris Diagnostics, A Division of IRIS International, Inc.",
    "510(k) Number": "K050235",
    "Predicate Device Reference 510(k) Number(s)": [
        "K914256",
        "K934539",
        "K954006",
        "K040073"
    ],
    "Regulatory Class": "Class II",
    "Product Code(s)": [
        "GKL"
    ],
    "Summary Letter Date": "March 23, 2005",
    "Summary Letter Received Date": "February 1, 2005",
    "Submission Date": "January 31, 2005",
    "Regulation Number(s)": [
        "21CFR864.5200"
    ],
    "Regulation Name(s)": [
        "Automated Cell Counter"
    ],
    "Analyte Class(es)": [
        "hematology"
    ],
    "Analyte(s)": [
        "Red blood cells",
        "Nucleated cells"
    ],
    "Specimen Type(s)": [
        "Cerebrospinal fluid",
        "Serous fluids"
    ],
    "Specimen Container(s)": [],
    "Instrument(s)/Platform(s)": [
        "iQ\u00ae 200 Urine Analyzer"
    ],
    "Method(s)/Technology(ies)": [
        "Flow microscopy",
        "Automated digital microscopy"
    ],
    "Methodologies": [
        "Microscopic cell counting"
    ],
    "Submission Type(s)": [
        "Analyzer",
        "Module"
    ],
    "Document Summary": "FDA 510(k) summary for iQ\u00ae 200 Urine Analyzer Body Fluids Module for automated RBC and nucleated cell counting in CSF and serous body fluids.",
    "Indications for Use Summary": "Used by a competent human observer to examine and count red blood cells and nucleated cells in cerebrospinal fluid and serous fluids to aid diagnosis of infections, hemorrhages, malignancies, and central nervous system disorders.",
    "fda_folder": "Hematology"
}